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Abstract
Efficient encapsulation of DNA plasmids inside small, neutral liposomes composed of 1,2-dioleoyl-sn-phosphatidylcholine
(DOPC), DOPC/DOPE (1,2-dioleoyl-sn-phosphatidylethanolamine) (1:1) and DOPC/DOPE/cholesterol (1:1:1) was
achieved by the addition of ethanol and calcium chloride to an aqueous mixture of small unilamellar vesicles (SUVs) and
plasmid. Following dialysis against low-salt buffer, the neutral lipid complexes (NLCs) had average effective diameters less
than 200 nm and encapsulated up to 80% of the DNA. Optimum Ca2 and ethanol concentrations for each lipid mixture
were determined by statistically designed experiments and mathematical modeling of trapping efficiency. NLCs are
unilamellar, have neutral surface potentials, and retain entrapped DNA at pH 4.0 and in serum at 37‡C. The circulation and
clearance properties of the complexes following intravenous administration in mice are similar to empty neutral liposomes,
and the toxicity of NLCs are expected to be significantly reduced compared to other non-viral gene-delivery systems. The
NLC encapsulation method, if it can be combined with effective targeting and endosome-release technologies to achieve
efficient and tissue-specific transfection, may represent an important alternative to current systemic gene therapy
approaches. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Systemic gene delivery using DNA plasmids com-
plexed with lipid vesicles or synthetic polymers o¡ers
an attractive alternative to recombinant viral vectors
for gene therapy, with the advantages of lower costs
of production and fewer safety concerns. While in
vivo transfection with existing cationic delivery sys-
tems can be achieved by local administration, e.g.
intratumoral injection, their charge properties and
physical characteristics limit their e⁄cacy in systemic
applications. Speci¢cally, the particles interact
strongly with serum proteins, often leading to disas-
sembly or clearance of the complexes before they can
reach target tissues. Positively charged cationic lipo-
some^plasmid complexes can passively target the
lungs when administered intravenously [1]. However,
the doses required for transfection of lung tissue us-
ing these complexes can be accompanied by vascular
leakage, resulting in a narrow therapeutic window.
Additionally, a strong cytokine response is associated
with lung transfection, which may be undesirable for
some applications [2]. Strategies to re-target cationic
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lipid^DNA complexes to other tissues and to reduce
lung-associated toxicity have met with some success
(for a review, see [3]).
Liposomes composed of neutral or zwitterionic lip-
ids have much longer circulation times, lower toxic-
ities, and very di¡erent clearance pro¢les compared
to cationic particles. Neutral liposomes have been
successfully applied as carriers for anti-cancer drugs
and antibiotics, to achieve lower toxicities, altered
distributions, and higher drug e⁄cacies than unen-
capsulated drugs (for reviews, [4^6]). Small, neutral
liposomes passively accumulate in tumors and sites
of in£ammation where the vasculature is malformed
or permeabilized [7]. In addition, re-targeting strat-
egies are more easily applied to neutral liposomes
than to cationic complexes, given their increased cir-
culation lifetimes. In terms of systemic delivery of
plasmids, however, neutral liposomes have two dis-
tinct disadvantages relative to cationic liposomes: a
lack of capacity to achieve any appreciable level of
transfection, and no existing methods for e⁄cient
entrapment of DNA plasmids in particles of su⁄-
ciently small size for systemic administration. The
problem of transfection is currently being addressed
by the use of pH-sensitive, membrane-lytic peptides
and polymers that can be grafted to liposomes to
deliver liposomal contents to the cytosol following
endocytosis. In this paper, we present a method to
e⁄ciently trap plasmids inside small neutral lipo-
somes.
The encapsulation of DNA plasmids in liposomes
has been achieved by a number of techniques with
varying degrees of success. The reverse-phase evapo-
ration method [8] produces large unilamellar lipo-
somes (average diameters of 400^500 nm) in which
up to 40% of plasmids can be trapped using nega-
tively charged, phosphatidylserine (PS)-containing
vesicles [9,10]. Dehydration^rehydration techniques
[11,12] have also been adapted with claims of greater
than 60% plasmid entrapment in oleic acid-contain-
ing vesicles, but most of the entrapped plasmid is
released by extrusion through 0.45-Wm ¢lters [13],
suggesting that the vesicles are very large. Smaller
vesicles prepared by a detergent dialysis method,
again with oleic acid in the lipid mixture, gave 15%
trapping in 200-nm liposomes [14]. A more obscure
method of entrapment by the addition of EDTA to
Ca2-PS cochleates in the presence of DNA has been
shown to be far less e⁄cient, with less than 1% trap-
ping achieved [15].
It is not straightforward to compare results from
these studies, since di¡erent mixtures of lipids and
variations in procedures can greatly in£uence trap-
ping e⁄ciencies. In many cases, charged lipids have
been used, either to enhance plasmid interactions or
to increase transfection in vitro. However, both the
membrane charge and the large particle sizes of these
preparations can be detrimental to in vivo delivery.
A direct comparison of three di¡erent encapsulation
techniques using the zwitterionic lipid POPC (1-pal-
mitoyl-2-oleoyl-sn-phosphatidylcholine) showed that
a freeze^thaw procedure [16] was superior (30% plas-
mid entrapped) to both the dehydration^rehydration
(14%) and the reverse-phase (11%) methods for en-
trapment in liposomes with average diameters less
than 200 nm [17]. In this study, plasmid entrapment
was enhanced by the addition of cationic lipids, but
inhibited in the presence of normal saline.
Given that the optimal liposome size for extended
circulation is 100^200 nm, the limiting factors in
achieving higher entrapment of plasmids in neutral
liposomes are: the relative size of the plasmid, with
average radii of gyration on the scale of 80^125 nm
depending on the sequence length and the supercoil^
open circle ratio [18]; and the low passive entrap-
ment volume for liposomes of this size. For example,
150-nm unilamellar liposomes at a lipid concentra-
tion of 10 mM contain only 3^5% of the total aque-
ous volume in which they are suspended. To over-
come these disadvantages, methods that either
condense the plasmid, or increase lipid^DNA inter-
actions, or both, are needed to increase the proba-
bility of plasmid entrapment.
The condensation of DNA by divalent metal ions
has been extensively studied. The transition metal
ions Mn2, Ni2, Co2, and Cu2 have all been
shown to condense DNA through neutralization of
the phosphate groups of the DNA backbone and
distortion of the B-DNA structure through hydrogen
bonding with bases, permitting both local bending of
the DNA and inter-helical associations [19^22]. The
concentrations of metal ions required for such con-
densation are known to be dependent on the dielec-
tric constant of the medium [23]. The addition of
ethanol or methanol greatly reduces the concentra-
tion of metal ion required [24]. Ethanol itself can also
BBAMEM 77924 22-9-00
A.L. Bailey, S.M. Sullivan / Biochimica et Biophysica Acta 1468 (2000) 239^252240
be used for controlled condensation of DNA at con-
centrations up to 60% by volume [25^27].
Calcium ions will also condense DNA, albeit at
higher concentrations than required for the transition
metal ions [28]. Recently, it has been shown that
Ca2 not only binds to DNA phosphates, but can
also form a complex with the nitrogen7 and oxy-
gen6 of guanine, disrupting base pairing [22]. The
potential advantages of using calcium for plasmid
condensation are: its lower binding a⁄nity for
DNA, making the condensation more easily reversed
by the removal of calcium or the competitive binding
of high concentrations of Na ; the wider concentra-
tion ranges over which condensation occurs, giving
greater control over this highly co-operative process;
and reduced potential toxicity owing to tight cellular
regulation of calcium.
Interestingly, calcium has also been shown to be
capable of mediating the binding of DNA to small
unilamellar vesicles (SUVs) composed of phosphati-
dylcholine (PC) and the encapsulation of DNA in-
side large POPC unilamellar vesicles (LUVs) pre-
pared by the reverse phase method described above
[29^31]. Uptake of up to 15% of a sonicated T7
phage DNA was achieved, reportedly by a mecha-
nism involving invagination and pinching o¡ of
smaller vesicles within the larger liposomes. Similar
results have since been reported by others using mul-
ti-lamellar vesicles (MLVs) [32] or extruded vesicles
[33] of PC, although the structures of the resulting
complexes were less well characterized in the latter
studies.
Given these reports of PC liposome entrapment of
DNA, and the stability and increased circulation
properties of PC bilayers relative to cationic lipo-
somes, we chose pure DOPC liposomes for our ini-
tial attempts to entrap plasmids using combinations
of calcium and ethanol. DOPC, with two mono-un-
saturated acyl chains, is liquid-crystalline at ambient
and physiological temperatures and forms more sta-
ble SUVs than the pure, saturated phosphatidylcho-
lines with comparable hydrocarbon chain lengths
[34]. However, DOPC has a higher propensity to
support membrane fusion relative to monounsatu-
rated lipids, e.g. POPC [35], a property that is desir-
able for the eventual release of entrapped DNA. The
propensity of DOPC bilayers to fuse with other
membranes can be increased by the addition of 1,2-
dioleoyl-sn-phosphatidylethanolamine (DOPE), a fu-
sogenic zwitterionic lipid. Cholesterol, while reducing
membrane permeability of PC membranes, can also
promote fusion as a result of its curvature-inducing
properties [36]. For these reasons, we have also
studied plasmid entrapment in DOPC/DOPE (1:1)
and DOPC/DOPE/Chol (1:1:1) mixtures, all of
which are charge-neutral.
We describe a method for trapping DNA plasmids
inside unilamellar liposomes with average diameters
less than 200 nm and trapping e⁄ciencies up to 80%.
Entrapment is induced by the simultaneous addition
of calcium and ethanol, followed by dialysis against
low-salt bu¡er. Optimized conditions for each of the
three lipid mixtures are determined. In addition to
size and entrapment analysis of the resulting neutral
lipid complexes (NLCs), the lamellarity, the in vitro
stability, and the biodistribution following intrave-
nous administration are reported.
2. Materials and methods
2.1. Materials
The phospholipids, 1,2-dioleoyl-sn-phosphatidyl-
choline (DOPC) and 1,2-dioleoyl-sn-phosphatidyleth-
anolamine (DOPE), cholesterol, and head-group la-
beled NBD-DOPE were purchased as chloroform
solutions from Avanti Polar Lipids (Alabaster,
AL). Tritium-labeled cholesteryl hexadecyl ether
was supplied by NEN (Boston, MA). Absolute etha-
nol was from Millennium Petrochemicals (Tuscola,
IL), and calcium chloride and sodium dithionite
were purchased from Sigma (St. Louis, MO). TO-
PRO-1, Indo-1, and Cyber Green were supplied by
Molecular Probes (Eugene, OR). Concentrated Tris^
HCl, pH 8.0, and phosphate bu¡ered saline, pH 7.4
(PBS), were from Gibco-BRL (Rockville, MD). Re-
generated cellulose dialysis tubing (3500 MWCO)
and pre-sterilized dialysis tubes (10 000 MWCO)
were supplied by Spectra/Por.
2.2. Liposome preparation
Chloroform solutions of lipids were mixed and
dried to a thin ¢lm by rotary evaporation. Residual
solvent was removed under high vacuum for at least
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4 h or overnight. Dried lipids were dispersed with
10 mM Tris bu¡er, pH 7.4 (TB7.4), to a concentra-
tion of 80 mM total lipid in volumes ranging from
1 to 5 ml. Small unilamellar vesicles (SUVs) were
formed by probe sonication (Fisher Scienti¢c). A
sonication program (¢ve cycles of 3-min pulsing, 1-
min o¡) and immersion of the sample tube in an ice
bath throughout the process were used to minimize
sample heating. Liposomes were then centrifuged at
12 000 rpm in an Eppendorf 5415C centrifuge for
5 min to remove debris, and ¢ltered through 0.2-
Wm sterilizing membranes.
2.3. Plasmid preparation
Plasmid (pCMV-CAT, 4377 bp) was isolated and
puri¢ed from Escherichia coli as described previously
[37]. The purity of plasmid preparations was deter-
mined by 1% agarose gel electrophoresis followed by
SYBR Green £uorescent staining. DNA concentra-
tion was measured by UV absorption at 260 nm. The
percentage of supercoiled pDNA was in the range of
80^95%, and the OD260=280 ratio was between 1.85
and 1.9. Endotoxin levels of pDNA were determined
using a chromogenic limulus amebocyte lysate assay
(LAL BioWhitaker, Walkersville, MD). Values were
less than 20 EU/mg.
2.4. Formation and optimization of NLCs
Neutral liposome complexes (NLCs) were formed
by ¢rst mixing SUVs (250 Wl, 20 Wmol), plasmid
(0.1 mg), and TB7.4 to give a total volume of
400 Wl. To this was added 600 Wl of a given mixture
of absolute ethanol, calcium chloride (from a 500 mM
stock) and TB7.4. Addition was drop-wise over ap-
proximately 30 s with maximum vortex mixing. The
resulting aggregated complexes were dialyzed against
500 vols. of TB7.4 for 24 h with two changes of
bu¡er. For experiments requiring physiological ton-
icity, samples were further dialyzed against 500 vols.
of PBS for 24 h.
For a given lipid composition, plasmid entrapment
and particle size were optimized using central com-
posite experimental designs with two factors (ethanol
and calcium concentrations) and four centerpoints.
Design and analysis were performed using Essential
Experiment Design, an add-in macro for Microsoft
Excel [38]. Factor ranges were estimated from pre-
liminary trapping experiments, and these were di¡er-
ent for each lipid composition: DOPC, 35^50% etha-
nol, 0^5 mM Ca2 ; DOPC/DOPE, 20^40% ethanol,
0^10 mM Ca2 ; DOPC/DOPE/Chol, 35^45% etha-
nol, 5^15 mM Ca2. Quadratic models with up to six
terms were ¢t to the measured entrapment data from
each design, but only those terms that contributed
signi¢cantly to the ¢t (P6 0.05) were used in predict-
ing optimal formulations. The criteria for optimiza-
tion were maximized entrapment and average par-
ticle size less than 200 nm. A single design was
required to optimize each lipid formulation, but
each was repeated to validate the resulting model
and terms.
2.5. Size analysis
Average particle diameters were determined by
quasi-elastic light scattering (QELS) using a BI-
9000AT correlator (Brookhaven Instruments, Holts-
ville, NY). Samples were diluted to 1.0 mM lipid in
water or PBS, as appropriate, to give su⁄cient scat-
tering intensity with a minimum pinhole (100 Wm).
Averages of three autocorrelations, each collected
over 1 min with a minimum scattering intensity of
5U104 counts/s, were converted to Gaussian distri-
butions, from which mean diameters and standard
deviations were derived using software supplied by
the manufacturer. Polydispersities were also noted.
2.6. Entrapment assay
The fraction of plasmid entrapped by the complex-
ation procedure was determined using the £uorescent
DNA probe TO-PRO-1 [39]. Complexes were diluted
100-fold into a total 2.0 ml volume with TB7.4, and
1 Wl of 1 mM TO-PRO-1 was added from a DMSO
stock solution. Fluorescence was measured on a Per-
kin-Elmer LS 50B spectro£uorometer, with excita-
tion and emission wavelengths of 514 and 531 nm,
respectively, 2.5 nm slit-widths, and the photo-multi-
plier voltage set to 900 V. The signal due to scatter
prior to the addition of TO-PRO-1 was set to zero
£uorescence. Percent entrapment was calculated as
the £uorescence signal of TO-PRO-1 divided by the
£uorescence following the addition of 20 Wl of 100
mM Triton X-100 to release DNA from the lipid,
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correcting for the 1% increase in volume. At the con-
centrations speci¢ed, the neutral lipids and Triton
X-100 were determined to have no e¡ect on TO-
PRO-1 £uorescence in the presence of free DNA
plasmids. Increasing the concentration of TO-PRO-
1 did not increase £uorescence, indicating that it is
present in su⁄cient excess.
2.7. Negative stain electron microscopy
Just prior to use, formar-coated 100-mesh copper
grids were prepared by glow discharging. Grids were
then £oated on 25 Wl of sample for 90 s, wicked o¡,
and £oated on drops of 1% aqueous uranyl acetate
for 90 s. Finally, samples were wicked o¡, air dried
and stored at room temperature. Negative stain elec-
tron micrographs of NLCs were taken using a JEOL
1200EX electron microscope, operating at 60 kV.
Images were recorded at a magni¢cation of
100 000U.
2.8. Zeta potential and lamellarity
Surface charges of SUVs and NLCs were mea-
sured on a Malvern Zetasizer 2000 using a dip cell
and disposable polyacrylate cuvettes. Samples were
diluted to 0.2 mM lipid in TB7.4 to achieve su⁄cient
signal with scatter less than 1.5U105 counts per sec-
ond. Measurements were made using the automated
procedure provided with the instrument.
Lamellarity of NLCs was measured by a proce-
dure adapted from Gruber and Schindler [40]. Com-
plexes with a ¢nal average diameter of approximately
150 nm were made from DOPC SUVs containing
0.1 mol% NBD-DOPE using the entrapment proce-
dure described above. Twenty microliters of NLCs or
5 Wl of SUVs were diluted to 2 ml in TB7.4 or PBS,
as appropriate, and £uorescence was monitored at
540 nm with excitation at 470 nm and 5 nm slit-
widths. After 2 min, 20 Wl of a freshly prepared so-
dium dithionite solution (prepared by mixing 348 mg
Na2S2O4 and 243 mg of Tris free base in 1.55 ml of
water) was added. Four minutes later, 20 Wl of
100 mM Triton X-100 was added to disrupt lipo-
somes and allow complete bleaching of the probe.
An experiment in which Triton X-100 was added
before dithionite was used to control for scatter by
the relatively large complexes in the absence of a
low-pass ¢lter. Lamellarity was calculated as de-
scribed in Fig. 3.
2.9. Stability assays
Ten milliliters of DOPC or DOPC/DOPE (1:1)
NLCs, prepared at optimized conditions, were con-
centrated to 1.0 ml (1.0 mg/ml DNA) in two Ultra-
free-15 Biomax 100 kDa nominal molecular weight
cut-o¡ centrifugal ¢lters (Millipore, Bedford, MA)
by spinning at 2500Ug for 30 min in a bench-top
centrifuge. Concentrated complexes were stored for
14 days at 4‡C, or diluted 10-fold into either PBS,
pH 4.0, or fetal bovine serum (Gibco-BRL, Rock-
ville, MD) and incubated at 37‡C for 1 h. Particle
size and entrapment of appropriately diluted com-
plexes were measured as described above.
2.10. In vivo distribution
Subcutaneous solid tumors were created in the
£anks of 6^8-week-old female C3H mice (20^22 g)
(Charles River Laboratories, Raleigh, NC) by s.c.
injection of 4U105 squamous carcinoma cells [41]
7 days prior to the experiment. For in vivo lipid
distributions, DOPC SUVs, radiolabeled with a trace
amount of the non-exchangeable lipid marker 3H-
cholesteryl hexadecyl ether (840 cpm/Wl), were pre-
pared by extrusion through 50 nm pore-size polycar-
bonate ¢lters (Millipore), using a LiposoFast ex-
truder (Avestin, Ottawa, ON). NLCs were formed
using optimized conditions for DOPC, followed by
concentration to 0.25 mg/ml DNA. Groups of ¢ve
mice were tail-vein injected with either 300 Wl of
NLCs or 300 Wl or an equivalent lipid dose of
SUVs without DNA. One hour after injection,
blood, tumors, livers, spleens, and lungs were har-
vested. Livers were homogenized in four parts water
by Polytron. Two hundred microliters of liver homo-
genate, 100 Wl blood, and other whole organs were
digested in 5 ml scintillation vials by the addition of
50 Wl 200 mM EDTA, 150 Wl 30% hydrogen perox-
ide, and 25 Wl 10 M HCl and incubating overnight at
50‡C. After the addition of 4.5 ml of ScintiSafe 50%
scintillation cocktail (Fisher Scienti¢c, Spring¢eld,
NJ) and a further 24 h incubation at room temper-
ature, radioactivity of the samples was measured us-
ing 5-min tritium counts on a Beckman LS6000SC.
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Background counts were determined from organs
harvested from uninjected mice.
In vivo distribution of plasmid was determined
after tail-vein administration of 300 Wl (90 Wg
DNA) unlabelled DOPC NLCs. Blood and organs
were digested by incubation in 100 mM NaCl,
10 mM Tris^HCl, pH 8.0, 25 mM EDTA, pH 8.0,
0.5% SDS, and proteinase K, 0.1 mg/ml, at 50‡C.
The samples were extracted with an equal volume
of Tris-bu¡ered phenol, followed by extraction with
chloroform/isoamyl alcohol (24:1, v/v) and ethanol
precipitation. The DNA precipitates were dissolved
in 10 mM Tris, pH 7.5, 1 mM EDTA, and DNA
concentration was measured by UV absorption at
260 nm. CAT plasmid was quanti¢ed by polymerase
chain reaction (PCR) using Taqman PCR (Perkin-
Elmer, Foster City, CA). The primers used in the
reaction were a forward primer, 5P-TGA CCT CCA
TAG AAG ACA CCG GGA C-3P (Genosys Bio-
technologies, The Woodlands, TX), which primes
in the CMV 5P-untranslated region (UTR), and a
reverse primer, 5P-GCA AGT CGA CCT ATA
ATG CCG-3P, which primes in the CAT coding re-
gion. The probe sequence was 5P-CCA GCC TCC
GGA CTC TAG AGG A-3P. The initial copy num-
bers of unknown samples were determined by using
an Applied Biosystem 7700 sequence detector to
compare them with a standard curve generated
from puri¢ed pCMV-CAT of known initial copy
numbers.
3. Results
The size of SUVs produced by the sonication pro-
cedure was dependent on lipid composition. DOPC
gave the smallest vesicles with mean diameters rang-
ing from 35 to 45 nm, and polydispersity indices
(P.I.) between 0.1 and 0.2. DOPC/DOPE (1:1) were
larger (70^80 nm), but more monodisperse
(P.I. = 0.08), due to the lower spontaneous curvature
of this lipid mixture and the tendency of small
vesicles to fuse spontaneously. Smaller DOPC/
DOPE (1:1) populations could be produced by ex-
trusion, but these spontaneously fused to larger sizes
within hours in the low-salt bu¡er. The DOPC/
DOPE/Chol (1:1:1) mixture could not produce
vesicles smaller than 100 nm in diameter, even after
doubling the sonication time or extrusion through
50-nm pore-size ¢lters. To minimize spontaneous fu-
sion of all SUVs prior to complexation with DNA,
NLCs were prepared on the day of the sonication
procedure.
Initial attempts to achieve entrapment of plasmids
in liposomes by the addition of ethanol, calcium, or
both ethanol and calcium were unsuccessful. Most
procedures tried either resulted in very large particles
or negligible entrapment of plasmid. Addition of
ethanol alone to SUV-plasmid mixtures gave high
entrapment of plasmid only with very large particle
sizes. Ca2 in the range of 2^20 mM was found to
limit the sizes of these complexes. However, the trap-
ping e⁄ciency was sensitive to small changes in the
calcium concentration, decreasing with increasing
calcium.
Attempts to ‘pre-condense’ the plasmid with etha-
nol and calcium before the addition of liposomes or
to destabilize liposomes by adding ethanol before the
addition of plasmid were also ine¡ective. It became
evident that condensation of the plasmid and aggre-
gation and fusion of the liposomes needed to occur
simultaneously in the mixture. Under these condi-
tions, the plasmid interactions with, and entrapment
in, fusing liposomes probably competes with conden-
sation and aggregation of the plasmid. The liposome
and plasmid concentrations are crucial parameters.
For 100 Wg/ml DNA, 20 mM lipid was required to
achieve sub-micron particle sizes. These concentra-
tions were used throughout the study. Assuming uni-
lamellar liposomes with an average ¢nal diameter of
150 nm, this ratio is equivalent to approximately one
plasmid for every two liposomes.
Physiological saline was found to prevent entrap-
ment of plasmid completely under all conditions
tried, even when very large lipid structures were
formed. The salt may act to compete with calcium
for binding to plasmid, thereby preventing condensa-
tion, and it may shield surface charges and prevent
calcium-bridged lipid^DNA interactions.
Since the nature of these interactions and the
mechanism of entrapment is unknown, we chose to
explore a range of ethanol and calcium ion concen-
trations to determine conditions that give maximum
entrapment of plasmid in particles less than 200 nm
in diameter. Statistically designed experiments pro-
vide a convenient means to study the e¡ects of simul-
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taneously varying ethanol and calcium ion concen-
trations, without making any assumptions about
their individual and correlated e¡ects on entrapment
and particle size. Extensive iterative titrations of each
of the components to ¢nd an optimal formulation
can be avoided.
We chose a central composite design with four
centerpoints, which for two variables results in 12
experiments per design. Ranges of ethanol and cal-
cium ion concentrations were chosen based on pre-
liminary experiments showing entrapment, and these
ranges are given in the methods. An example of such
a design, using DOPC/DOPE (1:1) SUVs, is given in
Table 1. Experiments were randomized within each
design. For each experiment, e¡ective diameters of
particles and percent plasmid entrapment were deter-
mined and entered into the analysis. The reproduc-
ibility of the procedure is evident from the center-
point repeats.
Quadratic models of increasing complexity were
used to ¢t the trapping e⁄ciency or the particle
size. The number of signi¢cant terms required to
achieve a ¢t varied with the lipid composition. In
the example shown, the resulting equation that best
describes the entrapment e⁄ciency (R2 = 0.95) was:
% Entrapment  94:0 2790  EtOH231100
EtOH 12:9  Ca2341:8  EtOH  Ca2
where EtOH is the fractional volume of ethanol and
the calcium concentration is given in millimolar
units. A comparison of plasmid entrapment pre-
dicted by this model with the experimental data is
shown in Fig. 1. The raw data is also plotted to
show that trapping e⁄ciency increases sharply over
a relatively narrow range of particle diameters, 120^
160 nm.
In a similar modeling procedure for the formation
of DOPC NLCs, only the square of the ethanol con-
centration and an inverse linear calcium term were
required for a highly signi¢cant ¢t to observed trap-
ping e⁄ciency (R2 = 0.99):
% Entrapment  351:2 532  EtOH232:5  Ca2
With DOPC/DOPE/Chol (1:1:1) the best ¢t was
Table 1
Partial output from Essential Experimental Design for optimization of entrapment with DOPC/DOPE (1:1) liposomes and pCMV-
CAT plasmid, 20^40% ethanol (v/v), 0^10 mM Ca2
Experimenta EtOH (v/v) Ca2 (mM) Size (nm) % Entrapment
1 0.300 5.00 113.7 14.29b
2 0.300 5.00 111.9 15.70b
3 0.229 8.54 116.7 15.49
4 0.300 0.00 86.3 0.33
5 0.371 8.54 117.8 42.07
6 0.371 1.46 262.5 69.55
7 0.200 5.00 118.1 30.06
8 0.300 5.00 110.9 13.83b
9 0.229 1.46 116.7 1.14
10 0.400 5.00 159.4 75.37
11 0.300 5.00 110.4 14.66b
12 0.300 10.00 105.5 16.23
Term Coe⁄cientc P value Standard error
Intercept 9.40E+01 1.20E301 5.31E+01
EtOHUEtOH 2.79E+03 1.38E303 5.46E+02
EtOH 31.11E+03 1.32E302 3.37E+02
Ca2 1.29E+01 1.99E302 4.29E+00
EtOHUCa2 34.18E+01 2.09E302 1.41E+01
aThe 12 experiments from the central composite design were randomized.
bFour centerpoint repeats.
cOptimized values for the intercept and the co-e⁄cients from a quadratic model, including all statistically signi¢cant terms (i.e.
P6 0.05) along with their standard errors.
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given by the same four-term model as for DOPC/
DOPE (1:1), (R2 = 0.92):
% Entrapment  310231538  EtOH2  901
EtOH33:7  Ca2  12:8  EtOH   Ca2:
The equations of best ¢t are purely empirical and
the co-e⁄cients may not have deducible physical
signi¢cance or any validity or outside of the factor
ranges used. The ¢ts were simply used to choose
optimal formulations within the experimental ranges.
More important conclusions might be drawn from
the relative signi¢cance of each of the terms in the
¢t. For all three lipid mixtures, the trapping e⁄-
ciency is primarily a function of the square of
the ethanol concentration, with P values ranging
from 6 1039 for DOPC up to 0.0014 for DOPC/
DOPE (1:1).
Analysis of the particle diameter data following
identical modeling procedures shows that the e¡ec-
tive diameter of the NLCs closely parallels trapping
e⁄ciency, except that higher calcium concentrations
play a signi¢cant role in reducing particle size for a
given trapping e⁄ciency. Therefore, we chose condi-
tions that maximized percent entrapped DNA, but
that also produced NLCs for which the majority of
particles would have e¡ective diameters less than
200 nm (i.e. mean+S.D. 9 200 nm). The optimal
conditions for each of the lipid mixtures studied
are given in Table 2.
For DOPC and DOPC/DOPE (1:1) the optimiza-
tion procedure was successful. Trapping e⁄ciencies
from 65^80% were achieved with average particle
sizes 140 and 160 nm, respectively. Lower ethanol
concentrations were required for the DOPE-contain-
ing liposomes, owing to their relative instability and
propensity to fuse. However, higher calcium ion con-
centrations were also required, indicating that calci-
um plays a role either directly, or indirectly through
plasmid e¡ects, in limiting the extent of liposome
fusion during NLC formation. It should be noted
that the reduction in size achieved at higher calcium
concentrations is not simply an osmotic e¡ect on the
Fig. 1. Graphical output from Essential Experimental Design
for optimization of entrapment with DOPC/DOPE (1:1) lipo-
somes and pCMV-CAT plasmid, 20^40% ethanol (v/v), 0^10
mM Ca2. (A) Correlation curve from the quadratic model de-
¢ned in Table 1, showing the level of ¢t to the experimental
data for entrapment. The line represents the model of best ¢t
with ¢ve terms. The error bars represent 95% con¢dence inter-
vals on predicted values. The solid line is a least squares ¢t
showing minimal deviation from slope = 1 (dotted line). (B)
Raw data from the 12 experiments in the design plotted as %
entrapped DNA vs. average e¡ective particle diameter.
Table 2
Concentrations of ethanol and Ca2 for optimized plasmid entrapment with three liposome compositions
Lipid composition Optimized formulation E¡ective diameter (nm) % Entrapmenta
DOPC 47.5% EtOH 4 mM Ca2 140 (30)b 65^70
DOPC/DOPE (1:1) 38% EtOH 8 mM Ca2 160 (40) 70^80
DOPC/DOPE/Chol (1:1:1) 38% EtOH 10 mM Ca2 s 200 35^40
aRanges are approximated from results from several independent designs.
bStandard deviations are in brackets.
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complexes, since sizes are determined following re-
moval of the calcium by dialysis.
In the case of DOPC/DOPE/Chol (1:1:1), it was
not possible to achieve small particles with high plas-
mid entrapment. The best conditions gave 30^40%
trapping e⁄ciency with particle sizes between 200
and 400 nm. The inability to form SUVs from these
lipids with diameters less than 100 nm, either by ex-
tended sonication or extrusion, likely contributes to
the large size of the complexes. During NLC forma-
tion, it may be that the highly unstable nature of
lipid bilayers composed of this mixture leads to a
higher rate of liposome^liposome fusion events
such that plasmid interactions are pre-empted. Per-
haps the number of liposome^plasmid interactions is
simply reduced in the presence of cholesterol. Be-
cause of the undesirably large size of these com-
plexes, further characterization of the NLCs was lim-
ited to the DOPC and DOPC/DOPE (1:1) systems.
Removal of ethanol and calcium by dialysis in the
formation of NLCs is essentially complete. While
ethanol, which is readily transported across lipid bi-
layers, was not expected to remain in the NLCs, the
amount of Ca2 remaining associated with the plas-
mid or inside the particles was not known. Determi-
nation of calcium ion concentration in DOPC NLCs
after dissolution with Triton X-100 detergent and
using Indo-1 as a sensor showed that s 99.8% of
the Ca2 was removed in the dialysis procedure
(data not shown). Given a trapped volume of
roughly 5^10% for 150-nm liposomes at a 20 mM
lipid concentration, it is clear that most of the cal-
cium is removed before the integrity of the NLC
membrane is established. The remaining calcium is
at a concentration 300-fold lower than DNA phos-
phates on a mole basis, which is certainly insu⁄cient
to maintain any condensed structure.
Association of the plasmid with the fused lipo-
somes in the NLCs was initially demonstrated by
1% agarose gel electrophoresis and by £oatation on
a 10% Ficoll gradient (data not shown). In both
cases, the majority of the plasmid remained associ-
ated with the lipid. However, neither of these meth-
ods demonstrates that the plasmid is actually encap-
sulated in, and protected by, the lipid. Entrapment of
plasmid measured by TO-PRO-1 binding con¢rms
that the NLC membrane is indeed impermeable to
small hydrophilic molecules. More importantly, it
demonstrates that the plasmid is likely to be pro-
tected from degrading enzymes in vivo. It has been
demonstrated previously [39] that inhibition of TO-
PRO-1 binding is predictive of nuclease-mediated
degradation. Indeed, this small-molecule probe can
likely access DNA in structures that sterically ex-
clude nucleases.
Further evidence that the fraction of plasmid pro-
tected from TO-PRO-1 binding is entrapped in the
NLC particles, and not merely bound externally to
the liposomes in a condensed form inaccessible to the
Table 3
Surface potentials of SUVs and NLCs prepared with two lipid
compositions
Lipids Form Zeta potential (mV)
DOPC SUVs 32.3 (6.4)
NLCsa 33.0 (6.4)
DOPC/DOPE(1:1) SUVs 310.7 (6.6)
NLCsb 39.5 (10.3)
aDOPC NLCs were prepared with 47.5% ethanol and 4 mM
Ca2, e¡ective diameter 133 nm, and trapping e⁄ciency 69%.
bDOPC/DOPE NLCs were prepared with 40% EtOH and 5 mM
Ca2, e¡ective diameter 159 nm, and trapping e⁄ciency 75%.
Fig. 2. Negative stain electron micrograph of NLCs formed
with DOPC SUVs and pCMV-CAT plasmid, 48% ethanol (v/v)
and 4.25 mM Ca2. The largest particle (upper left) appears to
be an aggregate of two relatively large NLCs. Magni¢cation,
27 000U, and the white bar of the inset indicates 100 nm.
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dye, comes from the surface potential measurements
given in Table 3. Both DOPC and DOPC/DOPE
(1:1) NLCs have zeta potentials identical to the
SUVs from which they were prepared. The values
indicate nearly neutral surfaces, with a slight negative
charge contributed by deprotonated PE. For com-
parison, a typical cationic lipid^DNA complex par-
ticle has a zeta potential of about +50 mV [37].
The DOPC NLCs observed by negative stain elec-
tron microscopy, shown in Fig. 2, are consistent with
the average particle size determined by light-scatter-
ing measurements. With this technique, liposomes
appear as light globules surrounded by dark areas
of uranyl acetate stain. Uncondensed DNA plasmids
are not visible using this technique. As expected, the
particles are not uniform in size. Calculated polydis-
persities from the autocorrelation function were typ-
ically 0.2^0.3. Yet, no particles with diameters great-
er than 250 nm were observed in any ¢elds. Judging
from the size and number of the smallest liposomes
visualized, more than half of the liposomes undergo
at least one fusion event, while the larger structures
must have been formed from 5 to 10 SUVs. It is
likely that the larger structures contain the most, if
not all, of the entrapped plasmid (V60% trapping
e⁄ciency), but there are no discernible morphologi-
cal di¡erences between the large and small lipo-
somes. The smooth continuous surfaces of most of
the particles clearly indicate that the liposomes have
indeed fused and are not merely aggregated.
The lamellarity of DOPC NLCs was determined
by an NBD bleaching assay (Fig. 3). The method
involves determining what fraction of the £uores-
cence of NBD-labeled lipid is rapidly lost upon the
addition of the reducing agent, sodium dithionite.
This fraction represents the fraction of lipid available
to the bulk solution. Any remaining NBD £uores-
cence arises from lipids either on the inner lea£et
of unilamellar vesicles or on all but the outermost
lea£et of MLVs. Since the measured £uorescence of
the NBD-DOPE is increased by scatter in the pres-
ence of liposomes, the fractional bleaching was cor-
rected for this scatter by subtracting the loss of signal
upon dispersing the liposomes with a non-ionic de-
tergent. This correction may be obviated by the use
of a low-pass cuto¡ ¢lter.
The determined lamellarity value for the DOPC
NLCs was 1.22 þ 0.01. This value indicates that the
majority of the lipids are present as unilamellar
vesicles. That the value is fractionally greater than
one suggests that at least some of the resulting lipo-
somes are bi- or multi-lamellar, or that some degree
of aggregation is present. The lamellarity measured
for DOPC SUVs (0.86 þ 0.01) is close to the expected
value, since small liposomes of high curvature have a
greater proportion of their lipids on the outer mono-
layer than the inner. For the NBD-DOPE containing
SUVs (77 þ 9 nm diameter), measured lamellarity
would be expected to be 0.89 þ 0.02, assuming an
arbitrary constant headgroup area per lipid and a
bilayer thickness of 4.0 nm.
DOPC and DOPC/DOPE (1:1) NLCs are physi-
cally stable for at least 2 weeks in PBS at 4‡C. No
changes in particle size or entrapment were found.
Even at pH 4.0 or in the presence of 90% bovine
serum for 1 h at 37‡C these physical parameters re-
main unchanged (Fig. 4). The apparent minor de-
crease in size for the serum-treated samples actually
arises from the light-scattering of serum particulates
at the dilution of the measurement, as depicted in the
serum-only control. No aggregation of NLCs or re-
lease of plasmid was detected. Stability was also
demonstrated by concentrating the NLCs ten-fold
Fig. 3. Determination of lamellarity for DOPC SUVs and
NLCs by dithionite bleaching of NBD-DOPE. SUVs were pre-
pared with 0.1 mol% NBD-DOPE in DOPC and were 77 þ 9
nm in diameter. NLCs formed with 47.5% ethanol and 4 mM
Ca2 were 150 þ 30 nm. Tabulated average lamellarities and
standard deviations are derived from three measurements of a
single DOPC NLC preparation.
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(1.0 mg/ml DNA) by ultra¢ltration using 100 K
MWCO ¢lters. Again, no change in size or entrap-
ment was observed.
The in vivo circulation properties of DOPC NLCs
were as expected for DOPC liposomes of the size
measured. The distribution of NLC-associated lipid
was determined following tail vein injection into mice
using a radiolabeled lipid marker, and compared to
SUVs (Fig. 5). After 1 h, about one-third of the
injected lipid is still in circulation, both for the
SUVs and the NLCs. This contrasts with cationic
lipid^plasmid complexes that are cleared from the
circulation within minutes [42]. The majority of the
remaining recovered lipid is found in the liver and
the spleen, as expected from previous reports with
neutral liposomes [7]. A greater proportion of
NLCs is found in these organs at 1 h than is ob-
served for SUVs, and this is probably due to the
larger particle size. Less than 2% of either SUVs or
NLCs accumulated in the lungs, again in contrast to
cationic lipid particles which accumulate substan-
tially in the lungs following i.v. injection in tumor-
bearing mice. Even less of the NLCs are found in the
implanted SCC-VII tumors, which, although highly
vascularized, may require longer times for signi¢cant
accumulation of SUVs or complexes.
Only 25% of the injected plasmid DNA, as deter-
mined by qPCR, was recovered from the isolated
tissues in these studies, compared to 60% of the lipid.
Considering that only 60% of the plasmid was ini-
tially entrapped, about 10% of that initially en-
trapped DNA is no longer detectable in the tissues
studies. Whether this di¡erence re£ects degradation
of the plasmid, release of the plasmid from some of
the liposomes in vivo, or di¡erences in the recovery
e⁄ciencies of the assays is not known. However, for
the plasmid that is detected, its distribution pattern is
roughly the same as that of the lipid marker, suggest-
ing that the DNA is still associated with and pro-
tected by the lipid. The highest amount of plasmid is
in the circulation, clearly showing that it is protected
from serum nucleases. The remainder is mainly dis-
tributed between the liver and the spleen in propor-
tions corresponding to the amounts of lipid found in
these organs. Less than 0.1% of the plasmid was
found in either the lungs or the tumors. In tissues
harvested at 18 h post-injection, only 0.05% total of
the injected plasmid dose could be detected in all
tissues analyzed (not shown).
Fig. 5. Distribution and recovery of lipid and plasmid from
DOPC NLCs 1 h following intravenous injection in mice. Lipid
was tracked with radiolabeled cholesteryl hexadecyl ether, plas-
mid by quantitative PCR. The total fraction of the injected
dose recovered is indicated in brackets. A control group in-
jected with DOPC SUVs is also shown. Error bars indicate
standard errors of the means with n = 5.
Fig. 4. Stability of DOPC and DOPC/DOPE (1:1) NLCs at pH
4.0 or in 90% fetal bovine serum for 1 h at 37‡C. (A) E¡ective
diameters from Gaussian ¢ts to light-scattering autocorrelations
with error bars indicating standard deviations of the ¢ts. (B)
Trapping e⁄ciencies determined from the TO-PRO-1 assay.
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4. Discussion
The entrapment of up to 80% of DNA plasmids
inside stable, uncharged liposomes smaller on aver-
age than 200 nm in diameter is a two- to three-fold
improvement over the best trapping e⁄ciency previ-
ously reported for liposomes of this size. Most other
techniques have given larger particles with consider-
ably lower entrapment levels. The highly e⁄cient
trapping process described here takes advantage of
several physical properties of plasmids, liposomes
and their interactions with ethanol and calcium ions.
The physical properties of the NLCs clearly show
that the plasmid DNA is entrapped inside liposomes
formed through ethanol- and calcium-induced fusion
of SUVs. Although it is conceivable that a very tight
aggregation of SUVs with plasmid entrapped inside
the aggregates could explain the lack of TO-PRO-1
binding and the lack of surface charge on the com-
plexes, the electron microscopy, the lamellarity and
all the stability results indicate a more robust struc-
ture. Furthermore, it is di⁄cult to imagine what
would provide the stable cohesive forces for such
aggregates after the complete removal of calcium
and ethanol. It may be possible to quantify the fu-
sion process using existing lipid mixing assays
[43,44], but the possibility of lipid probe transfer at
the high ethanol concentrations used in the forma-
tion of the NLCs would make the interpretation of
the results of such assays questionable.
Calcium ions are able to neutralize the phosphate
charges of the DNA backbone, as well as to disrupt
hydrogen bonding between base pairs. These process-
es are enhanced in the presence of ethanol, which
both reduces the dielectric constant of the medium,
to increase ionic interactions, and disorder the struc-
tured water around the native DNA. Ethanol alone
can precipitate DNA by this dehydration process,
promoting inter-helix association, but condensation
is likely to be more e⁄cient in the presence of Ca2,
which can decrease inter-helical spacing and increase
local bending through charge neutralization and
base-pair disruption.
Zwitterionic liposomes are also a¡ected in several
ways by the presence of ethanol and calcium. Etha-
nol £uidizes PC vesicles, making them more perme-
able to hydrophilic solutes, but, more importantly,
increasing their propensity to bend and permitting
the formation of the non-bilayer intermediates that
lead to fusion between vesicles [45]. This process
probably involves disruption of the ordered water
at membrane surface. Ethanol also £uidizes the bi-
layer by partitioning into the hydrocarbon region
and increasing lipid headgroup spacing. For satu-
rated phospholipids, ethanol can also induce interdi-
gitation of monolayers, decreasing bilayer thickness.
The nature of interactions between calcium ions
and a zwitterionic lipid surface is less clear. It is
evident from Budker’s work [29^31] that calcium
promotes plasmid^lipid interactions in the absence
of ethanol. This suggests that calcium is able to com-
plex to some arrangement of the PC headgroups,
possibly through a combination of ionic interactions
with phosphates and electronic interactions with oxy-
gen in the glycerol backbone. If this is so, the coun-
terions of calcium must also be involved in the com-
plex to maintain charge neutrality. Calcium has also
been observed to promote fusion of DSPC/Chol lipo-
somes to the plasma membrane of cells in vitro (Bai-
ley and Chernomordik, unpublished). These observa-
tions suggest that calcium salts either create defects
in lipid packing or promote curvature changes that
can lead to membrane fusion.
The mechanism of NLC formation is clearly a
complex process and probably involves several or
all of these e¡ects described above. Additionally, cal-
cium may be forming salt bridges between liposomes
and DNA to promote fusion and entrapment. In
contrast to earlier reports for calcium-induced en-
trapment [29], it is clear from the electron microsco-
py and size analysis that fusion between liposomes is
involved. Aggregation and fusion of liposomes, con-
densation of plasmid, and association of plasmid
with liposomes must all be occurring simultaneously
and interdependently. In the absence of plasmid, the
extent of liposome fusion is much less, judged by
particle size after dialysis. The dependence on calci-
um to achieve smaller particle sizes suggests that
condensing or condensed plasmid can bridge and
fuse fewer liposomes than uncondensed plasmid.
The choice of calcium over other divalent ions is
important because of calcium’s relatively weak abil-
ity to promote condensation. Attempts to entrap
DNA in neutral liposomes with Mn2 gave very
large particles with limited trapping. Magnesium
may behave more similarly to calcium, although it
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is reported to have lower binding a⁄nity. Also, the
ethanol used in the entrapment process could prob-
ably be replaced by methanol or another miscible,
dielectric-reducing solvent, but whether di¡erences
in either plasmid condensation or the liposome fu-
sion induced would give comparable trapping e⁄-
ciencies is not known.
The in vivo results clearly demonstrate the higher
stability of neutral liposomes as a carrier for DNA
plasmids compared to cationic lipid complexes. The
circulation properties of NLCs are essentially the
same as observed for empty liposomes, with about
one-third of the complexes still circulating in the
bloodstream after 1 h. While this clearance rate is
still faster than that achieved with combinations of
saturated PCs and cholesterol, it may be possible to
extend the circulation times of NLCs by the incor-
poration of sterically stabilizing components, e.g. lip-
id-anchored polyethylene glycol (PEG), acyl glucor-
onides, or gangliosides [46]. However, the circulation
properties of the NLCs as reported may be su⁄cient
to achieve targeting to speci¢c tissues using existing
antibody, carbohydrate, or peptide targeting strat-
egies [3].
The main concern is whether it will be possible to
achieve transfection with NLCs upon delivery to
cells. It was not expected that complexes made
from these neutral lipids would be able to mediate
release of entrapped plasmid from the endosomal
compartment following uptake by cells, thereby pre-
venting lysosomal degradation. NLCs were not af-
fected by low pH or serum in vitro. The ability to
achieve endosomal release is an important property
of the cationic lipid complexes, although the mecha-
nism of release and delivery to the nucleus with cat-
ionic lipids remain poorly understood. Indeed, initial
in vitro studies indicate that NLCs are taken up in
high copy number by several cell types, but little, if
any, signi¢cant transfection is observed. The applica-
tion of NLCs for systemic plasmid delivery may
therefore also require the inclusion of an endosomo-
lytic component, such as the low pH-triggered, mem-
brane-destabilizing peptides or polymers.
Of course, as the number of components in the
liposomes is increased, there is a risk that the plas-
mid trapping process will be negatively a¡ected. This
would almost certainly be the case for liposomes
bearing sterically stabilizing PEG, which would
have to be added after complex formation. However,
short targeting or fusogenic peptides anchored to the
liposomes may not impact on the trapping e⁄ciency,
or it may be possible to adjust the calcium and etha-
nol concentrations to maintain high plasmid entrap-
ment. The e¡ects of these components can be studied
using the statistical design and modeling process de-
scribed here.
The high level of plasmid entrapment achieved in
the NLC process described, certainly warrants con-
tinued investigation into their use as gene delivery
vehicles for systemic administration. The non-toxic
nature of neutral liposomes and the longer circula-
tion lifetimes of NLCs relative to other non-viral
systems are clear advantages. If it is indeed possible
to achieve tissue-speci¢c targeting and to overcome
the barriers to cytosolic and nuclear delivery with
existing or future technologies, NLCs will o¡er an
important alternative non-viral delivery system for
gene therapy.
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